Exicure Inc. (XCUR)
NASDAQ: XCUR
· Real-Time Price · USD
10.20
-0.30 (-2.86%)
At close: May 07, 2025, 12:29 PM
-2.86% (1D)
| Bid | 10.08 |
| Market Cap | 64.44M |
| Revenue (ttm) | 500K |
| Net Income (ttm) | -9.7M |
| EPS (ttm) | -4.75 |
| PE Ratio (ttm) | -2.15 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 10.45 |
| Volume | 6,985 |
| Avg. Volume (20D) | 31,998 |
| Open | 10.50 |
| Previous Close | 10.50 |
| Day's Range | 10.08 - 10.50 |
| 52-Week Range | 1.44 - 36.00 |
| Beta | 3.87 |
About XCUR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol XCUR
Website n/a
3 months ago
-15.07%
Exicure shares are trading higher after the compan...
Unlock content with
Pro Subscription
5 months ago
+35.86%
Exicure shares are trading higher after the company reported a year-over-year increase in Q3 PES results. Additionally, the company announced it entered into a purchase agreement for $1.3 million and $8.7 million in equity financing.
3 weeks ago · businesswire.com
Exicure, Inc. (Nasdaq: XCUR) Announces Their Next Step in Planning for a New Clinical Trial in Acute Myeloid Leukemia (AML)REDWOOD CITY, Calif.--(BUSINESS WIRE)--Exicure, Inc. Announces Their Next Step in Planning for a New Clinical Trial in Acute Myeloid Leukemia (AML).
